nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—CYP2E1—obesity	0.276	1	CbGaD
Dalfampridine—CYP2E1—Bupropion—obesity	0.0106	0.577	CbGbCtD
Dalfampridine—CYP2E1—Cimetidine—obesity	0.00775	0.423	CbGbCtD
Dalfampridine—KCNA10—respiratory system—obesity	0.00774	0.0424	CbGeAlD
Dalfampridine—KCNC3—hindbrain—obesity	0.00685	0.0375	CbGeAlD
Dalfampridine—KCNA2—hindbrain—obesity	0.00634	0.0347	CbGeAlD
Dalfampridine—KCND1—hindbrain—obesity	0.00606	0.0332	CbGeAlD
Dalfampridine—KCNC1—hindbrain—obesity	0.00582	0.0319	CbGeAlD
Dalfampridine—KCNA7—cardiovascular system—obesity	0.00529	0.0289	CbGeAlD
Dalfampridine—KCND2—hindbrain—obesity	0.00396	0.0217	CbGeAlD
Dalfampridine—KCNG3—cardiovascular system—obesity	0.00382	0.0209	CbGeAlD
Dalfampridine—KCNA1—hindbrain—obesity	0.00347	0.019	CbGeAlD
Dalfampridine—KCND3—hindbrain—obesity	0.00345	0.0189	CbGeAlD
Dalfampridine—KCNA4—adrenal cortex—obesity	0.00341	0.0187	CbGeAlD
Dalfampridine—KCNC2—pituitary gland—obesity	0.00338	0.0185	CbGeAlD
Dalfampridine—KCNF1—islet of Langerhans—obesity	0.00336	0.0184	CbGeAlD
Dalfampridine—KCNB1—cardiovascular system—obesity	0.0033	0.0181	CbGeAlD
Dalfampridine—KCNA4—cardiovascular system—obesity	0.00312	0.0171	CbGeAlD
Dalfampridine—KCNH3—pituitary gland—obesity	0.00302	0.0165	CbGeAlD
Dalfampridine—Pharyngolaryngeal pain—Bupropion—obesity	0.00301	0.0127	CcSEcCtD
Dalfampridine—Tremor—Methamphetamine—obesity	0.00301	0.0127	CcSEcCtD
Dalfampridine—KCNA5—islet of Langerhans—obesity	0.003	0.0164	CbGeAlD
Dalfampridine—Laryngeal pain—Bupropion—obesity	0.00298	0.0126	CcSEcCtD
Dalfampridine—KCNH8—pituitary gland—obesity	0.00292	0.016	CbGeAlD
Dalfampridine—Tremor—Benzphetamine—obesity	0.0029	0.0122	CcSEcCtD
Dalfampridine—KCND1—cardiovascular system—obesity	0.00283	0.0155	CbGeAlD
Dalfampridine—KCNA4—pituitary gland—obesity	0.00276	0.0151	CbGeAlD
Dalfampridine—KCNC1—cardiovascular system—obesity	0.00272	0.0149	CbGeAlD
Dalfampridine—KCNF1—adrenal cortex—obesity	0.00266	0.0146	CbGeAlD
Dalfampridine—Tremor—Phendimetrazine—obesity	0.00264	0.0112	CcSEcCtD
Dalfampridine—Chest discomfort—Sibutramine—obesity	0.00264	0.0111	CcSEcCtD
Dalfampridine—KCNS1—pituitary gland—obesity	0.00262	0.0144	CbGeAlD
Dalfampridine—KCNH1—endocrine gland—obesity	0.00262	0.0144	CbGeAlD
Dalfampridine—KCNH8—adrenal gland—obesity	0.00261	0.0143	CbGeAlD
Dalfampridine—KCNA3—digestive system—obesity	0.00259	0.0142	CbGeAlD
Dalfampridine—KCNC4—adipose tissue—obesity	0.0025	0.0137	CbGeAlD
Dalfampridine—KCNA3—adrenal gland—obesity	0.00246	0.0135	CbGeAlD
Dalfampridine—KCNA4—adrenal gland—obesity	0.00246	0.0135	CbGeAlD
Dalfampridine—KCNC1—pituitary gland—obesity	0.00241	0.0132	CbGeAlD
Dalfampridine—Balance disorder—Topiramate—obesity	0.00237	0.01	CcSEcCtD
Dalfampridine—Insomnia—Methamphetamine—obesity	0.00237	0.01	CcSEcCtD
Dalfampridine—KCNG1—endocrine gland—obesity	0.00234	0.0128	CbGeAlD
Dalfampridine—Dyspepsia—Methamphetamine—obesity	0.00231	0.00973	CcSEcCtD
Dalfampridine—Chest discomfort—Bupropion—obesity	0.0023	0.0097	CcSEcCtD
Dalfampridine—Insomnia—Benzphetamine—obesity	0.00229	0.00964	CcSEcCtD
Dalfampridine—KCNB1—endocrine gland—obesity	0.00226	0.0124	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Methamphetamine—obesity	0.00226	0.00954	CcSEcCtD
Dalfampridine—Tremor—Phenylpropanolamine—obesity	0.00226	0.00952	CcSEcCtD
Dalfampridine—KCNC4—adrenal gland—obesity	0.00224	0.0123	CbGeAlD
Dalfampridine—Constipation—Methamphetamine—obesity	0.00224	0.00945	CcSEcCtD
Dalfampridine—KCND3—islet of Langerhans—obesity	0.00223	0.0122	CbGeAlD
Dalfampridine—Dyspepsia—Benzphetamine—obesity	0.00222	0.00938	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Benzphetamine—obesity	0.00218	0.0092	CcSEcCtD
Dalfampridine—KCNA5—cardiovascular system—obesity	0.00217	0.0119	CbGeAlD
Dalfampridine—KCNQ1—islet of Langerhans—obesity	0.00216	0.0118	CbGeAlD
Dalfampridine—Tremor—Phentermine—obesity	0.00216	0.00911	CcSEcCtD
Dalfampridine—KCNF1—pituitary gland—obesity	0.00215	0.0118	CbGeAlD
Dalfampridine—KCNF1—adipose tissue—obesity	0.00214	0.0117	CbGeAlD
Dalfampridine—KCNS3—cardiovascular system—obesity	0.00213	0.0116	CbGeAlD
Dalfampridine—KCNQ3—cardiovascular system—obesity	0.00213	0.0116	CbGeAlD
Dalfampridine—KCND3—respiratory system—obesity	0.00211	0.0115	CbGeAlD
Dalfampridine—Insomnia—Phendimetrazine—obesity	0.00208	0.00878	CcSEcCtD
Dalfampridine—Urticaria—Methamphetamine—obesity	0.00208	0.00878	CcSEcCtD
Dalfampridine—Anxiety—Phenylpropanolamine—obesity	0.00204	0.00863	CcSEcCtD
Dalfampridine—KCNQ1—respiratory system—obesity	0.00204	0.0112	CbGeAlD
Dalfampridine—KCNA2—endocrine gland—obesity	0.00203	0.0111	CbGeAlD
Dalfampridine—Urticaria—Benzphetamine—obesity	0.00201	0.00847	CcSEcCtD
Dalfampridine—Confusional state—Phenylpropanolamine—obesity	0.00198	0.00837	CcSEcCtD
Dalfampridine—Constipation—Phendimetrazine—obesity	0.00197	0.00831	CcSEcCtD
Dalfampridine—Chest pain—Phentermine—obesity	0.00196	0.00828	CcSEcCtD
Dalfampridine—KCND1—endocrine gland—obesity	0.00194	0.0106	CbGeAlD
Dalfampridine—Hypersensitivity—Methamphetamine—obesity	0.00193	0.00814	CcSEcCtD
Dalfampridine—KCNA5—pituitary gland—obesity	0.00192	0.0105	CbGeAlD
Dalfampridine—KCNS3—pituitary gland—obesity	0.00188	0.0103	CbGeAlD
Dalfampridine—Tremor—Diethylpropion—obesity	0.00188	0.00793	CcSEcCtD
Dalfampridine—KCNS3—adipose tissue—obesity	0.00187	0.0103	CbGeAlD
Dalfampridine—Hypersensitivity—Benzphetamine—obesity	0.00186	0.00785	CcSEcCtD
Dalfampridine—KCND2—cardiovascular system—obesity	0.00185	0.0101	CbGeAlD
Dalfampridine—Hypotension—Phenylpropanolamine—obesity	0.00184	0.00775	CcSEcCtD
Dalfampridine—KCNA5—digestive system—obesity	0.0018	0.00987	CbGeAlD
Dalfampridine—Insomnia—Phenylpropanolamine—obesity	0.00178	0.0075	CcSEcCtD
Dalfampridine—Dyspnoea—Phenylpropanolamine—obesity	0.00175	0.0074	CcSEcCtD
Dalfampridine—Convulsion—Diethylpropion—obesity	0.00174	0.00733	CcSEcCtD
Dalfampridine—Dizziness—Methamphetamine—obesity	0.00173	0.00731	CcSEcCtD
Dalfampridine—KCNQ2—pituitary gland—obesity	0.00173	0.00948	CbGeAlD
Dalfampridine—KCNQ1—adrenal cortex—obesity	0.00171	0.00938	CbGeAlD
Dalfampridine—Chest pain—Diethylpropion—obesity	0.00171	0.00721	CcSEcCtD
Dalfampridine—Insomnia—Phentermine—obesity	0.0017	0.00718	CcSEcCtD
Dalfampridine—Anxiety—Diethylpropion—obesity	0.0017	0.00718	CcSEcCtD
Dalfampridine—Constipation—Phenylpropanolamine—obesity	0.00168	0.0071	CcSEcCtD
Dalfampridine—KCNS3—adrenal gland—obesity	0.00168	0.00921	CbGeAlD
Dalfampridine—Dizziness—Benzphetamine—obesity	0.00167	0.00705	CcSEcCtD
Dalfampridine—KCNF1—endocrine gland—obesity	0.00167	0.00912	CbGeAlD
Dalfampridine—Dyspepsia—Phentermine—obesity	0.00166	0.00699	CcSEcCtD
Dalfampridine—Headache—Methamphetamine—obesity	0.00164	0.00692	CcSEcCtD
Dalfampridine—KCND2—pituitary gland—obesity	0.00164	0.00898	CbGeAlD
Dalfampridine—KCND2—adipose tissue—obesity	0.00163	0.00895	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Phentermine—obesity	0.00163	0.00685	CcSEcCtD
Dalfampridine—Feeling abnormal—Phenylpropanolamine—obesity	0.00162	0.00684	CcSEcCtD
Dalfampridine—Anxiety—Cimetidine—obesity	0.00162	0.00683	CcSEcCtD
Dalfampridine—KCND3—cardiovascular system—obesity	0.00162	0.00884	CbGeAlD
Dalfampridine—Constipation—Phentermine—obesity	0.00161	0.00679	CcSEcCtD
Dalfampridine—Headache—Benzphetamine—obesity	0.00158	0.00668	CcSEcCtD
Dalfampridine—Confusional state—Cimetidine—obesity	0.00157	0.00663	CcSEcCtD
Dalfampridine—KCNQ1—cardiovascular system—obesity	0.00156	0.00856	CbGeAlD
Dalfampridine—Anaphylactic shock—Cimetidine—obesity	0.00156	0.00657	CcSEcCtD
Dalfampridine—Dizziness—Phendimetrazine—obesity	0.00152	0.00642	CcSEcCtD
Dalfampridine—Nausea—Benzphetamine—obesity	0.0015	0.00633	CcSEcCtD
Dalfampridine—Urticaria—Phentermine—obesity	0.0015	0.00631	CcSEcCtD
Dalfampridine—KCNA5—endocrine gland—obesity	0.00149	0.00815	CbGeAlD
Dalfampridine—Insomnia—Diethylpropion—obesity	0.00148	0.00625	CcSEcCtD
Dalfampridine—Dyspnoea—Diethylpropion—obesity	0.00146	0.00616	CcSEcCtD
Dalfampridine—Hypersensitivity—Phenylpropanolamine—obesity	0.00145	0.00611	CcSEcCtD
Dalfampridine—Headache—Phendimetrazine—obesity	0.00144	0.00608	CcSEcCtD
Dalfampridine—Dyspepsia—Diethylpropion—obesity	0.00144	0.00608	CcSEcCtD
Dalfampridine—KCND3—adipose tissue—obesity	0.00142	0.0078	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Diethylpropion—obesity	0.00141	0.00596	CcSEcCtD
Dalfampridine—Constipation—Diethylpropion—obesity	0.0014	0.00591	CcSEcCtD
Dalfampridine—KCNQ1—pituitary gland—obesity	0.00139	0.00758	CbGeAlD
Dalfampridine—KCNQ1—adipose tissue—obesity	0.00138	0.00755	CbGeAlD
Dalfampridine—Nausea—Phendimetrazine—obesity	0.00137	0.00577	CcSEcCtD
Dalfampridine—Asthenia—Phentermine—obesity	0.00135	0.0057	CcSEcCtD
Dalfampridine—Feeling abnormal—Diethylpropion—obesity	0.00135	0.00569	CcSEcCtD
Dalfampridine—Infestation NOS—Orlistat—obesity	0.00135	0.00569	CcSEcCtD
Dalfampridine—Infestation—Orlistat—obesity	0.00135	0.00569	CcSEcCtD
Dalfampridine—KCNQ2—endocrine gland—obesity	0.00134	0.00735	CbGeAlD
Dalfampridine—Constipation—Cimetidine—obesity	0.00133	0.00562	CcSEcCtD
Dalfampridine—Nasopharyngitis—Bupropion—obesity	0.00132	0.00557	CcSEcCtD
Dalfampridine—KCNS3—liver—obesity	0.00131	0.0072	CbGeAlD
Dalfampridine—Urinary tract infection—Orlistat—obesity	0.00131	0.00553	CcSEcCtD
Dalfampridine—Urticaria—Diethylpropion—obesity	0.0013	0.00549	CcSEcCtD
Dalfampridine—Dizziness—Phenylpropanolamine—obesity	0.0013	0.00549	CcSEcCtD
Dalfampridine—KCNQ1—digestive system—obesity	0.0013	0.00711	CbGeAlD
Dalfampridine—Feeling abnormal—Cimetidine—obesity	0.00128	0.00542	CcSEcCtD
Dalfampridine—KCND3—adrenal gland—obesity	0.00128	0.007	CbGeAlD
Dalfampridine—Urinary tract infection—Sibutramine—obesity	0.00127	0.00535	CcSEcCtD
Dalfampridine—Vomiting—Phenylpropanolamine—obesity	0.00125	0.00528	CcSEcCtD
Dalfampridine—Dizziness—Phentermine—obesity	0.00124	0.00525	CcSEcCtD
Dalfampridine—Rash—Phenylpropanolamine—obesity	0.00124	0.00523	CcSEcCtD
Dalfampridine—Dermatitis—Phenylpropanolamine—obesity	0.00124	0.00523	CcSEcCtD
Dalfampridine—KCNQ1—adrenal gland—obesity	0.00124	0.00677	CbGeAlD
Dalfampridine—Vomiting—Phentermine—obesity	0.0012	0.00505	CcSEcCtD
Dalfampridine—Rash—Phentermine—obesity	0.00119	0.00501	CcSEcCtD
Dalfampridine—Dermatitis—Phentermine—obesity	0.00119	0.005	CcSEcCtD
Dalfampridine—Headache—Phentermine—obesity	0.00118	0.00497	CcSEcCtD
Dalfampridine—Nausea—Phenylpropanolamine—obesity	0.00117	0.00493	CcSEcCtD
Dalfampridine—Hypersensitivity—Cimetidine—obesity	0.00115	0.00484	CcSEcCtD
Dalfampridine—Infestation NOS—Bupropion—obesity	0.00114	0.0048	CcSEcCtD
Dalfampridine—Infestation—Bupropion—obesity	0.00114	0.0048	CcSEcCtD
Dalfampridine—Nausea—Phentermine—obesity	0.00112	0.00472	CcSEcCtD
Dalfampridine—Asthenia—Cimetidine—obesity	0.00112	0.00472	CcSEcCtD
Dalfampridine—Urinary tract infection—Bupropion—obesity	0.00111	0.00467	CcSEcCtD
Dalfampridine—Immune system disorder—Orlistat—obesity	0.00109	0.00461	CcSEcCtD
Dalfampridine—Mediastinal disorder—Orlistat—obesity	0.00109	0.0046	CcSEcCtD
Dalfampridine—Dizziness—Diethylpropion—obesity	0.00108	0.00457	CcSEcCtD
Dalfampridine—KCNQ1—endocrine gland—obesity	0.00107	0.00587	CbGeAlD
Dalfampridine—Angiopathy—Sibutramine—obesity	0.00106	0.00448	CcSEcCtD
Dalfampridine—Mental disorder—Orlistat—obesity	0.00106	0.00447	CcSEcCtD
Dalfampridine—Immune system disorder—Sibutramine—obesity	0.00106	0.00446	CcSEcCtD
Dalfampridine—Vomiting—Diethylpropion—obesity	0.00104	0.00439	CcSEcCtD
Dalfampridine—Rash—Diethylpropion—obesity	0.00103	0.00436	CcSEcCtD
Dalfampridine—Dermatitis—Diethylpropion—obesity	0.00103	0.00435	CcSEcCtD
Dalfampridine—Dizziness—Cimetidine—obesity	0.00103	0.00435	CcSEcCtD
Dalfampridine—Headache—Diethylpropion—obesity	0.00103	0.00433	CcSEcCtD
Dalfampridine—Back pain—Orlistat—obesity	0.00102	0.0043	CcSEcCtD
Dalfampridine—Connective tissue disorder—Bupropion—obesity	0.001	0.00423	CcSEcCtD
Dalfampridine—KCND3—liver—obesity	0.000999	0.00547	CbGeAlD
Dalfampridine—Vomiting—Cimetidine—obesity	0.000991	0.00418	CcSEcCtD
Dalfampridine—Back pain—Sibutramine—obesity	0.000987	0.00416	CcSEcCtD
Dalfampridine—Rash—Cimetidine—obesity	0.000982	0.00414	CcSEcCtD
Dalfampridine—Dermatitis—Cimetidine—obesity	0.000982	0.00414	CcSEcCtD
Dalfampridine—Headache—Cimetidine—obesity	0.000976	0.00412	CcSEcCtD
Dalfampridine—Nausea—Diethylpropion—obesity	0.000973	0.0041	CcSEcCtD
Dalfampridine—KCNQ1—liver—obesity	0.000967	0.0053	CbGeAlD
Dalfampridine—Angioedema—Orlistat—obesity	0.000963	0.00406	CcSEcCtD
Dalfampridine—Tremor—Sibutramine—obesity	0.000956	0.00403	CcSEcCtD
Dalfampridine—Angioedema—Sibutramine—obesity	0.000932	0.00393	CcSEcCtD
Dalfampridine—Angiopathy—Bupropion—obesity	0.000927	0.00391	CcSEcCtD
Dalfampridine—Nausea—Cimetidine—obesity	0.000925	0.0039	CcSEcCtD
Dalfampridine—Immune system disorder—Bupropion—obesity	0.000923	0.00389	CcSEcCtD
Dalfampridine—Mediastinal disorder—Bupropion—obesity	0.000921	0.00388	CcSEcCtD
Dalfampridine—Convulsion—Orlistat—obesity	0.000913	0.00385	CcSEcCtD
Dalfampridine—Chest pain—Orlistat—obesity	0.000897	0.00378	CcSEcCtD
Dalfampridine—Mental disorder—Bupropion—obesity	0.000895	0.00377	CcSEcCtD
Dalfampridine—Anxiety—Orlistat—obesity	0.000894	0.00377	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000891	0.00376	CcSEcCtD
Dalfampridine—Convulsion—Sibutramine—obesity	0.000884	0.00373	CcSEcCtD
Dalfampridine—Chest pain—Sibutramine—obesity	0.000868	0.00366	CcSEcCtD
Dalfampridine—Anxiety—Sibutramine—obesity	0.000865	0.00365	CcSEcCtD
Dalfampridine—Anaphylactic shock—Orlistat—obesity	0.00086	0.00363	CcSEcCtD
Dalfampridine—Back pain—Bupropion—obesity	0.00086	0.00363	CcSEcCtD
Dalfampridine—Infection—Orlistat—obesity	0.000855	0.0036	CcSEcCtD
Dalfampridine—Nervous system disorder—Orlistat—obesity	0.000844	0.00356	CcSEcCtD
Dalfampridine—Nasopharyngitis—Topiramate—obesity	0.000841	0.00355	CcSEcCtD
Dalfampridine—Confusional state—Sibutramine—obesity	0.000839	0.00354	CcSEcCtD
Dalfampridine—Skin disorder—Orlistat—obesity	0.000836	0.00352	CcSEcCtD
Dalfampridine—Tremor—Bupropion—obesity	0.000833	0.00351	CcSEcCtD
Dalfampridine—Anaphylactic shock—Sibutramine—obesity	0.000833	0.00351	CcSEcCtD
Dalfampridine—Infection—Sibutramine—obesity	0.000827	0.00349	CcSEcCtD
Dalfampridine—KCNH2—islet of Langerhans—obesity	0.000825	0.00451	CbGeAlD
Dalfampridine—Angioedema—Bupropion—obesity	0.000813	0.00343	CcSEcCtD
Dalfampridine—Skin disorder—Sibutramine—obesity	0.000809	0.00341	CcSEcCtD
Dalfampridine—Insomnia—Orlistat—obesity	0.000778	0.00328	CcSEcCtD
Dalfampridine—Hypotension—Sibutramine—obesity	0.000778	0.00328	CcSEcCtD
Dalfampridine—Paraesthesia—Orlistat—obesity	0.000772	0.00326	CcSEcCtD
Dalfampridine—Convulsion—Bupropion—obesity	0.00077	0.00325	CcSEcCtD
Dalfampridine—Dyspepsia—Orlistat—obesity	0.000757	0.00319	CcSEcCtD
Dalfampridine—Chest pain—Bupropion—obesity	0.000757	0.00319	CcSEcCtD
Dalfampridine—Anxiety—Bupropion—obesity	0.000754	0.00318	CcSEcCtD
Dalfampridine—Insomnia—Sibutramine—obesity	0.000753	0.00318	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000752	0.00317	CcSEcCtD
Dalfampridine—Paraesthesia—Sibutramine—obesity	0.000748	0.00315	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Orlistat—obesity	0.000743	0.00313	CcSEcCtD
Dalfampridine—Dyspnoea—Sibutramine—obesity	0.000742	0.00313	CcSEcCtD
Dalfampridine—Dyspepsia—Sibutramine—obesity	0.000733	0.00309	CcSEcCtD
Dalfampridine—Confusional state—Bupropion—obesity	0.000732	0.00309	CcSEcCtD
Dalfampridine—Anaphylactic shock—Bupropion—obesity	0.000726	0.00306	CcSEcCtD
Dalfampridine—Infestation NOS—Topiramate—obesity	0.000725	0.00306	CcSEcCtD
Dalfampridine—Infestation—Topiramate—obesity	0.000725	0.00306	CcSEcCtD
Dalfampridine—Infection—Bupropion—obesity	0.000721	0.00304	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Sibutramine—obesity	0.000719	0.00303	CcSEcCtD
Dalfampridine—Constipation—Sibutramine—obesity	0.000712	0.003	CcSEcCtD
Dalfampridine—Nervous system disorder—Bupropion—obesity	0.000712	0.003	CcSEcCtD
Dalfampridine—Feeling abnormal—Orlistat—obesity	0.000709	0.00299	CcSEcCtD
Dalfampridine—Skin disorder—Bupropion—obesity	0.000705	0.00297	CcSEcCtD
Dalfampridine—Urinary tract infection—Topiramate—obesity	0.000705	0.00297	CcSEcCtD
Dalfampridine—Feeling abnormal—Sibutramine—obesity	0.000686	0.00289	CcSEcCtD
Dalfampridine—Urticaria—Orlistat—obesity	0.000683	0.00288	CcSEcCtD
Dalfampridine—Hypotension—Bupropion—obesity	0.000678	0.00286	CcSEcCtD
Dalfampridine—Urticaria—Sibutramine—obesity	0.000661	0.00279	CcSEcCtD
Dalfampridine—Insomnia—Bupropion—obesity	0.000656	0.00277	CcSEcCtD
Dalfampridine—Paraesthesia—Bupropion—obesity	0.000652	0.00275	CcSEcCtD
Dalfampridine—Dyspnoea—Bupropion—obesity	0.000647	0.00273	CcSEcCtD
Dalfampridine—Connective tissue disorder—Topiramate—obesity	0.00064	0.0027	CcSEcCtD
Dalfampridine—Dyspepsia—Bupropion—obesity	0.000639	0.00269	CcSEcCtD
Dalfampridine—Hypersensitivity—Orlistat—obesity	0.000634	0.00267	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Bupropion—obesity	0.000627	0.00264	CcSEcCtD
Dalfampridine—Constipation—Bupropion—obesity	0.000621	0.00262	CcSEcCtD
Dalfampridine—Asthenia—Orlistat—obesity	0.000617	0.0026	CcSEcCtD
Dalfampridine—Hypersensitivity—Sibutramine—obesity	0.000613	0.00259	CcSEcCtD
Dalfampridine—CYP2E1—respiratory system—obesity	0.0006	0.00328	CbGeAlD
Dalfampridine—Feeling abnormal—Bupropion—obesity	0.000598	0.00252	CcSEcCtD
Dalfampridine—Asthenia—Sibutramine—obesity	0.000597	0.00252	CcSEcCtD
Dalfampridine—KCNH2—cardiovascular system—obesity	0.000596	0.00326	CbGeAlD
Dalfampridine—Angiopathy—Topiramate—obesity	0.00059	0.00249	CcSEcCtD
Dalfampridine—Immune system disorder—Topiramate—obesity	0.000588	0.00248	CcSEcCtD
Dalfampridine—Mediastinal disorder—Topiramate—obesity	0.000587	0.00247	CcSEcCtD
Dalfampridine—Urticaria—Bupropion—obesity	0.000577	0.00243	CcSEcCtD
Dalfampridine—Mental disorder—Topiramate—obesity	0.00057	0.00241	CcSEcCtD
Dalfampridine—Dizziness—Orlistat—obesity	0.000569	0.0024	CcSEcCtD
Dalfampridine—Dizziness—Sibutramine—obesity	0.000551	0.00232	CcSEcCtD
Dalfampridine—Back pain—Topiramate—obesity	0.000548	0.00231	CcSEcCtD
Dalfampridine—Vomiting—Orlistat—obesity	0.000547	0.00231	CcSEcCtD
Dalfampridine—Rash—Orlistat—obesity	0.000542	0.00229	CcSEcCtD
Dalfampridine—Dermatitis—Orlistat—obesity	0.000542	0.00229	CcSEcCtD
Dalfampridine—Headache—Orlistat—obesity	0.000539	0.00227	CcSEcCtD
Dalfampridine—Hypersensitivity—Bupropion—obesity	0.000535	0.00226	CcSEcCtD
Dalfampridine—Tremor—Topiramate—obesity	0.000531	0.00224	CcSEcCtD
Dalfampridine—Vomiting—Sibutramine—obesity	0.000529	0.00223	CcSEcCtD
Dalfampridine—KCNH2—pituitary gland—obesity	0.000528	0.00289	CbGeAlD
Dalfampridine—Rash—Sibutramine—obesity	0.000525	0.00221	CcSEcCtD
Dalfampridine—Dermatitis—Sibutramine—obesity	0.000524	0.00221	CcSEcCtD
Dalfampridine—Headache—Sibutramine—obesity	0.000522	0.0022	CcSEcCtD
Dalfampridine—Asthenia—Bupropion—obesity	0.000521	0.0022	CcSEcCtD
Dalfampridine—Nausea—Orlistat—obesity	0.000511	0.00216	CcSEcCtD
Dalfampridine—Nausea—Sibutramine—obesity	0.000494	0.00209	CcSEcCtD
Dalfampridine—Convulsion—Topiramate—obesity	0.000491	0.00207	CcSEcCtD
Dalfampridine—Chest pain—Topiramate—obesity	0.000482	0.00203	CcSEcCtD
Dalfampridine—Anxiety—Topiramate—obesity	0.000481	0.00203	CcSEcCtD
Dalfampridine—Dizziness—Bupropion—obesity	0.00048	0.00202	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000479	0.00202	CcSEcCtD
Dalfampridine—KCNH2—adrenal gland—obesity	0.000472	0.00258	CbGeAlD
Dalfampridine—Confusional state—Topiramate—obesity	0.000466	0.00197	CcSEcCtD
Dalfampridine—Vomiting—Bupropion—obesity	0.000461	0.00195	CcSEcCtD
Dalfampridine—Infection—Topiramate—obesity	0.000459	0.00194	CcSEcCtD
Dalfampridine—CYP2E1—cardiovascular system—obesity	0.000459	0.00251	CbGeAlD
Dalfampridine—Rash—Bupropion—obesity	0.000458	0.00193	CcSEcCtD
Dalfampridine—Dermatitis—Bupropion—obesity	0.000457	0.00193	CcSEcCtD
Dalfampridine—Headache—Bupropion—obesity	0.000455	0.00192	CcSEcCtD
Dalfampridine—Nervous system disorder—Topiramate—obesity	0.000453	0.00191	CcSEcCtD
Dalfampridine—Skin disorder—Topiramate—obesity	0.000449	0.00189	CcSEcCtD
Dalfampridine—Hypotension—Topiramate—obesity	0.000432	0.00182	CcSEcCtD
Dalfampridine—Nausea—Bupropion—obesity	0.000431	0.00182	CcSEcCtD
Dalfampridine—Insomnia—Topiramate—obesity	0.000418	0.00176	CcSEcCtD
Dalfampridine—Paraesthesia—Topiramate—obesity	0.000415	0.00175	CcSEcCtD
Dalfampridine—Dyspnoea—Topiramate—obesity	0.000412	0.00174	CcSEcCtD
Dalfampridine—KCNH2—endocrine gland—obesity	0.000409	0.00224	CbGeAlD
Dalfampridine—Dyspepsia—Topiramate—obesity	0.000407	0.00172	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Topiramate—obesity	0.000399	0.00168	CcSEcCtD
Dalfampridine—Constipation—Topiramate—obesity	0.000395	0.00167	CcSEcCtD
Dalfampridine—CYP2E1—digestive system—obesity	0.000381	0.00209	CbGeAlD
Dalfampridine—Feeling abnormal—Topiramate—obesity	0.000381	0.00161	CcSEcCtD
Dalfampridine—Urticaria—Topiramate—obesity	0.000367	0.00155	CcSEcCtD
Dalfampridine—CYP2E1—adrenal gland—obesity	0.000363	0.00199	CbGeAlD
Dalfampridine—Hypersensitivity—Topiramate—obesity	0.000341	0.00144	CcSEcCtD
Dalfampridine—Asthenia—Topiramate—obesity	0.000332	0.0014	CcSEcCtD
Dalfampridine—CYP2E1—endocrine gland—obesity	0.000315	0.00172	CbGeAlD
Dalfampridine—Dizziness—Topiramate—obesity	0.000306	0.00129	CcSEcCtD
Dalfampridine—Vomiting—Topiramate—obesity	0.000294	0.00124	CcSEcCtD
Dalfampridine—Rash—Topiramate—obesity	0.000292	0.00123	CcSEcCtD
Dalfampridine—Dermatitis—Topiramate—obesity	0.000291	0.00123	CcSEcCtD
Dalfampridine—Headache—Topiramate—obesity	0.00029	0.00122	CcSEcCtD
Dalfampridine—CYP2E1—liver—obesity	0.000284	0.00156	CbGeAlD
Dalfampridine—Nausea—Topiramate—obesity	0.000275	0.00116	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—PPARGC1A—obesity	3.84e-05	0.000134	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNB3—obesity	3.84e-05	0.000134	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—obesity	3.82e-05	0.000133	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—obesity	3.82e-05	0.000133	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMOX1—obesity	3.82e-05	0.000133	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—obesity	3.79e-05	0.000132	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GNAS—obesity	3.73e-05	0.00013	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GNAS—obesity	3.73e-05	0.00013	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNAS—obesity	3.73e-05	0.00013	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—COMT—obesity	3.69e-05	0.000129	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GGT1—obesity	3.66e-05	0.000128	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOB—obesity	3.66e-05	0.000128	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOB—obesity	3.66e-05	0.000128	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOB—obesity	3.66e-05	0.000128	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GNB3—obesity	3.64e-05	0.000127	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARGC1A—obesity	3.64e-05	0.000127	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TYK2—obesity	3.62e-05	0.000126	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TYK2—obesity	3.62e-05	0.000126	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—obesity	3.62e-05	0.000126	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—NCOA1—obesity	3.61e-05	0.000126	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RHOA—obesity	3.59e-05	0.000125	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RHOA—obesity	3.59e-05	0.000125	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP19A1—obesity	3.55e-05	0.000124	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GNAS—obesity	3.54e-05	0.000124	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—PRKCB—obesity	3.52e-05	0.000123	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP19A1—obesity	3.51e-05	0.000122	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—LPL—obesity	3.49e-05	0.000122	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LPL—obesity	3.49e-05	0.000122	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—LPL—obesity	3.49e-05	0.000122	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOB—obesity	3.47e-05	0.000121	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GPX1—obesity	3.41e-05	0.000119	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GPX1—obesity	3.41e-05	0.000119	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GPX1—obesity	3.41e-05	0.000119	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA3—obesity	3.33e-05	0.000116	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CD36—obesity	3.32e-05	0.000116	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CD36—obesity	3.32e-05	0.000116	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CD36—obesity	3.32e-05	0.000116	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LPL—obesity	3.31e-05	0.000116	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—COMT—obesity	3.3e-05	0.000115	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—COMT—obesity	3.26e-05	0.000114	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GPX1—obesity	3.23e-05	0.000113	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CD36—obesity	3.15e-05	0.00011	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—obesity	3.14e-05	0.00011	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—obesity	3.14e-05	0.00011	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—obesity	3.14e-05	0.00011	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARA—obesity	3.08e-05	0.000108	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARA—obesity	3.08e-05	0.000108	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARA—obesity	3.08e-05	0.000108	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AGT—obesity	2.99e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AGT—obesity	2.99e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AGT—obesity	2.99e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—obesity	2.98e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOE—obesity	2.93e-05	0.000102	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOE—obesity	2.93e-05	0.000102	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOE—obesity	2.93e-05	0.000102	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARA—obesity	2.92e-05	0.000102	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAV1—obesity	2.9e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAV1—obesity	2.9e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAV1—obesity	2.9e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOA1—obesity	2.89e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOA1—obesity	2.89e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOA1—obesity	2.89e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—obesity	2.85e-05	9.96e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—obesity	2.85e-05	9.96e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AGT—obesity	2.83e-05	9.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GLRX—obesity	2.83e-05	9.88e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOE—obesity	2.77e-05	9.69e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAV1—obesity	2.75e-05	9.6e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—obesity	2.75e-05	9.6e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOA1—obesity	2.74e-05	9.58e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—obesity	2.64e-05	9.23e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—obesity	2.64e-05	9.23e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—obesity	2.64e-05	9.23e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—obesity	2.55e-05	8.91e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—obesity	2.55e-05	8.91e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—obesity	2.55e-05	8.91e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—obesity	2.53e-05	8.85e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—obesity	2.53e-05	8.85e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—INSIG2—obesity	2.52e-05	8.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPM1L—obesity	2.52e-05	8.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—OTC—obesity	2.52e-05	8.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ETFDH—obesity	2.52e-05	8.8e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—POMC—obesity	2.51e-05	8.78e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—POMC—obesity	2.51e-05	8.78e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—POMC—obesity	2.51e-05	8.78e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—obesity	2.5e-05	8.75e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—INS—obesity	2.5e-05	8.73e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—INS—obesity	2.5e-05	8.73e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—INS—obesity	2.5e-05	8.73e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—obesity	2.48e-05	8.66e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—obesity	2.48e-05	8.66e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARG—obesity	2.42e-05	8.44e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—POMC—obesity	2.38e-05	8.33e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—INS—obesity	2.37e-05	8.28e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—obesity	2.35e-05	8.21e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—obesity	2.35e-05	8.21e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—obesity	2.32e-05	8.11e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—obesity	2.32e-05	8.11e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—obesity	2.32e-05	8.11e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPT—obesity	2.31e-05	8.05e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—INPP5E—obesity	2.31e-05	8.05e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UQCRC2—obesity	2.31e-05	8.05e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—obesity	2.29e-05	8.01e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—obesity	2.29e-05	8.01e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—obesity	2.29e-05	8.01e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—obesity	2.22e-05	7.74e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—obesity	2.2e-05	7.69e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—obesity	2.19e-05	7.66e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—obesity	2.19e-05	7.66e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3R1—obesity	2.19e-05	7.66e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NOS3—obesity	2.19e-05	7.66e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3R1—obesity	2.19e-05	7.66e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NOS3—obesity	2.19e-05	7.66e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NOS3—obesity	2.19e-05	7.66e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3R1—obesity	2.19e-05	7.66e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—obesity	2.17e-05	7.59e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDH6A1—obesity	2.14e-05	7.48e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ME1—obesity	2.14e-05	7.48e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SUCLG2—obesity	2.14e-05	7.48e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—POMC—obesity	2.14e-05	7.46e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3R1—obesity	2.08e-05	7.26e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NOS3—obesity	2.08e-05	7.26e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—obesity	2.02e-05	7.07e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—obesity	2.02e-05	7.07e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—obesity	2.02e-05	7.07e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COX7C—obesity	2.01e-05	7.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PNPLA3—obesity	2.01e-05	7.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UCP1—obesity	2.01e-05	7.04e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—obesity	2.01e-05	7.01e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—obesity	2.01e-05	7.01e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—obesity	2.01e-05	7.01e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—obesity	1.92e-05	6.7e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DGAT2—obesity	1.91e-05	6.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CS—obesity	1.91e-05	6.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SUCLA2—obesity	1.91e-05	6.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CPS1—obesity	1.91e-05	6.67e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—obesity	1.9e-05	6.64e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LIPE—obesity	1.82e-05	6.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MUT—obesity	1.82e-05	6.36e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—obesity	1.77e-05	6.18e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—obesity	1.77e-05	6.18e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DGAT1—obesity	1.75e-05	6.1e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYB5A—obesity	1.75e-05	6.1e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACLY—obesity	1.68e-05	5.87e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—obesity	1.63e-05	5.7e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—obesity	1.63e-05	5.7e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENPP1—obesity	1.62e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALOX12—obesity	1.62e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMGCS1—obesity	1.57e-05	5.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PNPLA2—obesity	1.53e-05	5.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PFKFB3—obesity	1.53e-05	5.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLIN1—obesity	1.53e-05	5.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SAT1—obesity	1.53e-05	5.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ANGPTL4—obesity	1.53e-05	5.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACADM—obesity	1.53e-05	5.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACACB—obesity	1.49e-05	5.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYTB—obesity	1.49e-05	5.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—OXCT1—obesity	1.49e-05	5.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SRD5A1—obesity	1.45e-05	5.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PNLIP—obesity	1.45e-05	5.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SDC3—obesity	1.41e-05	4.93e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STS—obesity	1.38e-05	4.82e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP26B1—obesity	1.38e-05	4.82e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HK2—obesity	1.38e-05	4.82e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARD—obesity	1.35e-05	4.72e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC27A1—obesity	1.32e-05	4.62e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FABP4—obesity	1.3e-05	4.53e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GLUL—obesity	1.3e-05	4.53e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—obesity	1.23e-05	4.31e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—obesity	1.23e-05	4.31e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—obesity	1.23e-05	4.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ECHS1—obesity	1.23e-05	4.3e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UCP3—obesity	1.23e-05	4.3e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UCP2—obesity	1.23e-05	4.3e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD11B1—obesity	1.23e-05	4.3e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADH1B—obesity	1.21e-05	4.23e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPAM—obesity	1.19e-05	4.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARGC1B—obesity	1.19e-05	4.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACSL1—obesity	1.19e-05	4.16e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—obesity	1.17e-05	4.09e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PCK1—obesity	1.16e-05	4.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HADH—obesity	1.16e-05	4.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FADS1—obesity	1.16e-05	4.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACP5—obesity	1.13e-05	3.93e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—G6PD—obesity	1.1e-05	3.83e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SREBF2—obesity	1.08e-05	3.78e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HK1—obesity	1.08e-05	3.78e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LPA—obesity	1.05e-05	3.66e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LPIN1—obesity	1.02e-05	3.58e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—obesity	1.01e-05	3.52e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—obesity	1.01e-05	3.52e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—obesity	1.01e-05	3.52e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOA5—obesity	1e-05	3.5e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CLOCK—obesity	9.57e-06	3.34e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC22A1—obesity	9.57e-06	3.34e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—obesity	9.56e-06	3.34e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SULT2A1—obesity	9.33e-06	3.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GLP1R—obesity	9.33e-06	3.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DPYD—obesity	9.18e-06	3.21e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PRKAR2B—obesity	8.83e-06	3.09e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DCN—obesity	8.77e-06	3.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CPT1A—obesity	8.53e-06	2.98e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NAMPT—obesity	8.37e-06	2.92e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LIPC—obesity	8.31e-06	2.9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCK—obesity	8.31e-06	2.9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOC3—obesity	8.26e-06	2.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CETP—obesity	8.02e-06	2.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SDC1—obesity	7.93e-06	2.77e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1C3—obesity	7.8e-06	2.73e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SCARB1—obesity	7.68e-06	2.68e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SREBF1—obesity	7.46e-06	2.6e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GOT2—obesity	7.25e-06	2.53e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FASN—obesity	7.1e-06	2.48e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BCHE—obesity	7.07e-06	2.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NQO1—obesity	6.74e-06	2.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A4—obesity	6.47e-06	2.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCG—obesity	6.47e-06	2.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYCS—obesity	6.38e-06	2.23e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GGT1—obesity	6.26e-06	2.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GOT1—obesity	6.26e-06	2.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA1—obesity	6.17e-06	2.15e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STK11—obesity	6.08e-06	2.12e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP19A1—obesity	6.08e-06	2.12e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COMT—obesity	5.65e-06	1.97e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARGC1A—obesity	5.57e-06	1.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNB3—obesity	5.57e-06	1.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—obesity	5.55e-06	1.94e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNAS—obesity	5.43e-06	1.9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOB—obesity	5.31e-06	1.86e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LPL—obesity	5.07e-06	1.77e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPX1—obesity	4.95e-06	1.73e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CD36—obesity	4.82e-06	1.68e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—obesity	4.57e-06	1.6e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARA—obesity	4.48e-06	1.57e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AGT—obesity	4.34e-06	1.52e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOE—obesity	4.25e-06	1.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAV1—obesity	4.21e-06	1.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOA1—obesity	4.2e-06	1.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—obesity	3.84e-06	1.34e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—obesity	3.7e-06	1.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—POMC—obesity	3.65e-06	1.28e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—INS—obesity	3.63e-06	1.27e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—obesity	3.37e-06	1.18e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—obesity	3.33e-06	1.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3R1—obesity	3.19e-06	1.11e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NOS3—obesity	3.19e-06	1.11e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—obesity	2.94e-06	1.03e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—obesity	2.91e-06	1.02e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—obesity	1.79e-06	6.26e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—obesity	1.46e-06	5.12e-06	CbGpPWpGaD
